Inventor · disambiguated record
Aymen Al-Shamkhani
Also filed as: AL-SHAMKHANI AYMEN
8 granted patents·3 pending applications·156 citations·filing 1993–2022
86Inventor score
Files withUNIV SOUTHAMPTON4BIOINVENT INT AB2CANCER RESEARCH TECH LTD2BLINK BIOMEDICAL SAS1GLENNIE MARTIN JOHN1
Top patents by PatentIndex Score
11 records- 0192US9926374B2Human immune therapies using a CD27 agonist in combination with another immune agonist to treat cancerUNIV SOUTHAMPTON·Filed 2015·Granted Mar 27, 2018·13 cites·12 claims
- 0292US8481029B2Human immune therapies using a CD27 agonist alone or in combination with other immune modulatorsGLENNIE MARTIN JOHN·Filed 2007·Granted Jul 9, 2013·50 cites·18 claims
- 0391US9248183B2Human immune therapies using a CD27 agonist alone or in combination with other immune modulatorsUNIV SOUTHAMPTON·Filed 2013·Granted Feb 2, 2016·17 cites·17 claims
- 0483US5622718AAlginate-bioactive agent conjugatesUNIV KEELE·Filed 1993·Granted Apr 22, 1997·74 cites·29 claims
- 0573US11447549B2Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibodyBIOINVENT INT AB·Filed 2018·Granted Sep 20, 2022·1 cites·14 claims
- 0673US11001638B2Immunomodulatory antibodiesCANCER RESEARCH TECH LTD·Filed 2016·Granted May 11, 2021·1 cites·4 claims
- 0764US11780929B2Immunomodulatory antibodiesCANCER RESEARCH TECH LTD·Filed 2021·Granted Oct 10, 2023·0 cites·3 claims
- 0863US2023058227A1Novel antibodies and combined use of a treg depleting antibody and an immunostimulatory antibodyBIOINVENT INT AB·Filed 2022·Application pending·0 cites
- 0960US2018273631A1Human immune therapies using a cd27 agonist in combination with another immune agonist to treat cancerUNIV SOUTHAMPTON·Filed 2018·Application pending·0 cites
- 1041US12325754B2Cancer and B-cell related disease therapyUNIV SOUTHAMPTON·Filed 2017·Granted Jun 10, 2025·0 cites·16 claims
- 1137US2023192845A1Cd96-binding agents as immunomodulatorsBLINK BIOMEDICAL SAS·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aymen Al-Shamkhani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →